SAN FRANCISCO — Critically ill patients who receive stress ulcer prophylaxis suffer more adverse events with proton pump inhibitors (PPI) than with histamine 2 (H2) receptor antagonists, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results